DBV Technologies (DBVT) Other Working Capital Changes (2020 - 2026)
DBV Technologies (DBVT) reported Other Working Capital Changes of -$600000.0 for Q1 2026, down 116.22% year-over-year from $3.7 million in Q1 2025, and down 138.1% quarter-over-quarter from -$252000.0 in Q4 2025.
DBV Technologies (DBVT) Other Working Capital Changes (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Other Working Capital Changes data on file, last reported at -$600000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$600000.0, down 116.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $399000.0 (up 107.66% YoY), and the FY2025 annual result was $4.7 million, up 201.51% from the prior year.
- Other Working Capital Changes slipped to -$600000.0 in Q1 2026 per DBVT's latest filing, from -$252000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.7 million in Q1 2025 and troughed at -$20.5 million in Q1 2022.
- A 5-year average of -$1.2 million and a median of -$61000.0 in 2022 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes tumbled 5006.0% in 2022, then surged 343.11% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$61000.0 in 2022, then tumbled by 3268.85% to -$2.1 million in 2023, then tumbled by 327.35% to -$8.8 million in 2024, then surged by 97.13% to -$252000.0 in 2025, then sank by 138.1% to -$600000.0 in 2026.
- Business Quant data shows DBVT's Other Working Capital Changes at -$600000.0 in Q1 2026, -$252000.0 in Q4 2025, and $994000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -600,000.00 |
| Mar 31, 2026 | -600,000.00 |
| Dec 31, 2025 | -252,000.00 |
| Dec 31, 2025 | -252,000.00 |
| Sep 30, 2025 | 994,000.00 |
| Sep 30, 2025 | 994,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | -8.78 Mn |
| Dec 31, 2024 | -8.78 Mn |
| Sep 30, 2024 | -1.83 Mn |
| Sep 30, 2024 | -1.83 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 835,000.00 |
| Mar 31, 2024 | 835,000.00 |
| Dec 31, 2023 | -2.06 Mn |
| Dec 31, 2023 | -2.06 Mn |